Table 3 Logistic model for prevalence use in lifetime and last month among males and females
Lifetime use | ||||
|---|---|---|---|---|
Males (M) | Females (F) | |||
Parameter | OR (CI 0.95) | p-value | OR (CI 0.95) | p-value |
Trend 2000–2005 (one year) | 0.95 (0.94;0.96) | *** | 0.96 (0.95;0.96) | *** |
Trend 2005–2010 (one year) | 1.04 (1.03;1.04) | *** | 1.05 (1.04;1.06) | *** |
Age (one year) | 1.30 (1.29;1.31) | *** | 1.27 (1.26;1.28) | *** |
(Risk & No Availability) vs (No Risk & No Availability) | 0.59 (0.56;0.63) | *** | 0.63 (0.60;0.67) | *** |
(No Risk & Availability) vs (No Risk & No Availability) | 3.59 (3.42;3.76) | *** | 4.71 (4.47;4.97) | *** |
(Risk & Availability) vs (No Risk & No Availability) | 2.44 (2.33;2.55) | *** | 2.93 (2.79;3.08) | *** |
Last month use | ||||
Parameter | OR (CI 0.95) | p-value | OR (CI 0.95) | p-value |
Trend 2000–2005 (one year) | 0.99 (0.98;1.00) | n.s. | 1.00 (0.99;1.01) | n.s. |
Trend 2005–2010 (one year) | 1.00 (0.99;1.01) | n.s. | 1.00 (0.99;1.00) | n.s. |
Age (one year) | 1.30 (1.29;1.31) | *** | 1.17 (1.16;1.18) | *** |
(Risk & No Availability) vs (No Risk & No Availability) | 0.51 (0.47;0.55) | *** | 0.53 (0.48;0.57) | *** |
(No Risk & Availability) vs (No Risk & No Availability) | 3.55 (3.34;3.76) | *** | 4.82 (4.51;5.15) | *** |
(Risk & Availability) vs (No Risk & No Availability) | 2.31 (2.18;2.44) | *** | 2.98 (2.80;3.18) | *** |